Enveric Biosciences, Inc. (NASDAQ:ENVB) filed a Form 8-K with the Securities and Exchange Commission on February 06, 2026, disclosing a material event.
Enveric Biosciences, Inc.'s stock currently trades at $2.37 with a market capitalization of $3.2M. The Healthcare company's stock moved following the disclosure.